| Year |
Citation |
Score |
| 2024 |
Volkov J, Nunez D, Mozaffar T, Stadanlick J, Werner M, Vorndran Z, Ellis A, Williams J, Cicarelli J, Lam Q, Furmanak T, Schmitt C, Hadi-Nezhad F, Thompson D, Miller C, et al. Case study of CD19-directed chimeric antigen receptor T-cell therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis™ phase I/II trial. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 39245937 DOI: 10.1016/j.ymthe.2024.09.009 |
0.323 |
|
| 2020 |
Quinn WJ, Jiao J, TeSlaa T, Stadanlick J, Wang Z, Wang L, Akimova T, Angelin A, Schäfer PM, Cully MD, Perry C, Kopinski PK, Guo L, Blair IA, Ghanem LR, et al. Lactate Limits T Cell Proliferation via the NAD(H) Redox State. Cell Reports. 33: 108500. PMID 33326785 DOI: 10.1016/j.celrep.2020.108500 |
0.675 |
|
| 2019 |
Klampatsa A, O'Brien SM, Thompson JC, Rao AS, Stadanlick JE, Martinez MC, Liousia M, Cantu E, Cengel K, Moon EK, Singhal S, Eruslanov EB, Albelda SM. Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes. Oncoimmunology. 8: e1638211. PMID 31428531 DOI: 10.1080/2162402X.2019.1638211 |
0.396 |
|
| 2019 |
Singhal S, Stadanlick J, Annunziata MJ, Rao AS, Bhojnagarwala PS, O'Brien S, Moon EK, Cantu E, Danet-Desnoyers G, Ra HJ, Litzky L, Akimova T, Beier UH, Hancock WW, Albelda SM, et al. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer. Science Translational Medicine. 11. PMID 30760579 DOI: 10.1126/Scitranslmed.Aat1500 |
0.337 |
|
| 2018 |
Shilling D, Stadanlick JE, Meng W, Rao A, Krymskaya VP, Luning Prak ET, Eruslanov EB, Fajgenbaum DC. Oligoclonal Expansion of Cd8+ T Cells during Idiopathic Multicentric Castleman Disease Flares Suggests an Antigen Driven Process Blood. 132: 2411-2411. DOI: 10.1182/Blood-2018-99-118650 |
0.306 |
|
| 2017 |
Predina JD, Newton AD, Connolly C, Dunbar A, Baldassari M, Deshpande C, Cantu E, Stadanlick J, Kularatne SA, Low PS, Singhal S. Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29241970 DOI: 10.1016/J.Ymthe.2017.10.016 |
0.339 |
|
| 2017 |
Akimova T, Zhang T, Negorev D, Singhal S, Stadanlick J, Rao A, Annunziata M, Levine MH, Beier UH, Diamond JM, Christie JD, Albelda SM, Eruslanov EB, Hancock WW. Human lung tumor FOXP+ Tregs upregulate four "Treg-locking" transcription factors. Jci Insight. 2. PMID 28814673 DOI: 10.1172/Jci.Insight.94075 |
0.301 |
|
| 2016 |
Solanki NR, Stadanlick JE, Zhang Y, Duc AC, Lee SY, Lauritsen JP, Zhang Z, Wiest DL. Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling. Journal of Immunology (Baltimore, Md. : 1950). PMID 27489283 DOI: 10.4049/Jimmunol.1600815 |
0.351 |
|
| 2016 |
Rao S, Cai KQ, Stadanlick JE, Greenberg-Kushnir N, Solanki-Patel N, Lee SY, Fahl SP, Testa JR, Wiest DL. Ribosomal protein Rpl22 controls the dissemination of T cell lymphoma. Cancer Research. PMID 27197189 DOI: 10.1158/0008-5472.Can-15-2698 |
0.403 |
|
| 2015 |
Rao S, Cai K, Stadanlick J, Lee S, Greenberg-Kushnir N, Solanki-Patel N. Novel Role for Rpl22 in Controlling Lymphoma Progression and Dissemination Blood. 126: 3669-3669. DOI: 10.1182/Blood.V126.23.3669.3669 |
0.434 |
|
| 2015 |
Rao S, Stadanlick JE, Cai KQ, David WL. Abstract A07: Loss of Rpl22 promotes tumor progression through regulation of angiogenesis and dissemination. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-A07 |
0.334 |
|
| 2015 |
Rao S, Stadanlick JE, Cai KQ, Wiest DL. Abstract 5215: Loss of Rpl22 promotes tumor progression through regulation of angiogenesis Cancer Research. 75: 5215-5215. DOI: 10.1158/1538-7445.Am2015-5215 |
0.331 |
|
| 2011 |
Stadanlick JE, Zhang Z, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL. Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors. Journal of Immunology (Baltimore, Md. : 1950). 187: 664-75. PMID 21690328 DOI: 10.4049/Jimmunol.1100029 |
0.353 |
|
| 2010 |
Lee SY, Stadanlick J, Kappes DJ, Wiest DL. Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice. Seminars in Immunology. 22: 237-46. PMID 20471282 DOI: 10.1016/J.Smim.2010.04.008 |
0.435 |
|
| 2009 |
Treml JF, Hao Y, Stadanlick JE, Cancro MP. The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochemistry and Biophysics. 53: 1-16. PMID 19034695 DOI: 10.1007/S12013-008-9036-1 |
0.824 |
|
| 2009 |
Crowley JE, Stadanlick JE, Cambier JC, Cancro MP. FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood. 113: 1464-73. PMID 18791164 DOI: 10.1182/Blood-2008-02-138651 |
0.831 |
|
| 2008 |
Stadanlick JE, Kaileh M, Karnell FG, Scholz JL, Miller JP, Quinn WJ, Brezski RJ, Treml LS, Jordan KA, Monroe JG, Sen R, Cancro MP. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nature Immunology. 9: 1379-87. PMID 18978795 DOI: 10.1038/Ni.1666 |
0.747 |
|
| 2008 |
Crowley JE, Scholz JL, Quinn WJ, Stadanlick JE, Treml JF, Treml LS, Hao Y, Goenka R, O'Neill PJ, Matthews AH, Parsons RF, Cancro MP. Homeostatic control of B lymphocyte subsets. Immunologic Research. 42: 75-83. PMID 18668213 DOI: 10.1007/S12026-008-8036-Y |
0.645 |
|
| 2008 |
Stadanlick JE, Cancro MP. BAFF and the plasticity of peripheral B cell tolerance. Current Opinion in Immunology. 20: 158-61. PMID 18456486 DOI: 10.1016/J.Coi.2008.03.015 |
0.756 |
|
| 2007 |
Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 7531-9. PMID 17548587 DOI: 10.4049/Jimmunol.178.12.7531 |
0.818 |
|
| 2006 |
Stadanlick JE, Cancro MP. Unraveling the warp and weft of B cell fate. Immunity. 25: 395-6. PMID 16979572 DOI: 10.1016/J.Immuni.2006.09.001 |
0.659 |
|
| 2006 |
Miller JP, Stadanlick JE, Cancro MP. Space, selection, and surveillance: setting boundaries with BLyS. Journal of Immunology (Baltimore, Md. : 1950). 176: 6405-10. PMID 16709796 DOI: 10.4049/Jimmunol.176.11.6405 |
0.858 |
|
| 2005 |
Crowley JE, Treml LS, Stadanlick JE, Carpenter E, Cancro MP. Homeostatic niche specification among naïve and activated B cells: a growing role for the BLyS family of receptors and ligands. Seminars in Immunology. 17: 193-9. PMID 15826824 DOI: 10.1016/J.Smim.2005.02.001 |
0.787 |
|
| Show low-probability matches. |